A Phase 2 Study Evaluating the Co-Administration of Bremelanotide With Tirzepatide for the Treatment of Obesity (opens ClinicalTrials.gov)
- Sponsor
- Palatin Technologies, Inc
- Enrolment
- 108
- Started
- 2024-08-05
- Last update
- 2025-03-06
Conditions: Obesity
Interventions: bremelanotide, tirzepatide